Significance of Preoperative Systemic Immune Score for Stage I Gastric Cancer Patients.

Jun LuLong-Long CaoPing LiJian-Wei XieJia-Bin WangJian-Xian LinQi-Yue ChenMi LinRu-Hong TuChang-Ming Huang Chao-Hui Zheng

Published in: Gastroenterology research and practice (2018)

Patients with SIS = 2 may benefit from AC and thus may be considered candidates for adjuvant treatment. However, to confirm our findings, future prospective studies are warranted.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
early stage
peritoneal dialysis
patients undergoing
prognostic factors
patient reported outcomes
combination therapy
smoking cessation